Role of C-terminal negative charges and tyrosine residues in fibril formation of α-synuclein
- PMID: 23139905
- PMCID: PMC3489812
- DOI: 10.1002/brb3.86
Role of C-terminal negative charges and tyrosine residues in fibril formation of α-synuclein
Abstract
α-Synuclein (140 amino acids), one of the causative proteins of Parkinson's disease, forms amyloid fibrils in brain neuronal cells. In order to further explore the contributions of the C-terminal region of α-synuclein in fibril formation and also to understand the overall mechanism of fibril formation, we reduced the number of negatively charged residues in the C-terminal region using mutagenesis. Mutants with negative charges deleted displayed accelerated fibril formation compared with wild-type α-synuclein, demonstrating that negative charges located in the C-terminal region of α-synuclein modulate fibril formation. Additionally, when tyrosine residues located at position 125, 133, and 136 in the C-terminal region were changed to alanine residue(s), we found that all mutants containing the Tyr136Ala mutation showed delays in fibril formation compared with wild type. Mutation of Tyr136 to various amino acids revealed that aromatic residues located at this position act favorably toward fibril formation. In mutants where charge neutralization and tyrosine substitution were combined, we found that these two factors influence fibril formation in complex fashion. These findings highlight the importance of negative charges and aromatic side chains in the C-terminal region of α-synuclein in fibril formation.
Keywords: Amyloid; Parkinson's disease; amyloid formation mechanism; protein aggregation; site-directed mutagenesis; α-Synuclein.
Figures








Similar articles
-
The role of the acidic domain of α-synuclein in amyloid fibril formation: a molecular dynamics study.J Biomol Struct Dyn. 2016;34(2):376-83. doi: 10.1080/07391102.2015.1033016. Epub 2015 May 1. J Biomol Struct Dyn. 2016. PMID: 25869255
-
A pH-dependent switch promotes β-synuclein fibril formation via glutamate residues.J Biol Chem. 2017 Sep 29;292(39):16368-16379. doi: 10.1074/jbc.M117.780528. Epub 2017 Jul 14. J Biol Chem. 2017. PMID: 28710275 Free PMC article.
-
Modification of C Terminus Provides New Insights into the Mechanism of α-Synuclein Aggregation.Biophys J. 2017 Nov 21;113(10):2182-2191. doi: 10.1016/j.bpj.2017.08.027. Epub 2017 Sep 20. Biophys J. 2017. PMID: 28939194 Free PMC article.
-
The effect of tyrosine residues on α-synuclein fibrillation.Acta Chim Slov. 2015;62(1):181-9. doi: 10.17344/acsi.2014.882. Acta Chim Slov. 2015. PMID: 25830974
-
Interplay of α-synuclein with Lipid Membranes: Cooperative Adsorption, Membrane Remodeling and Coaggregation.JACS Au. 2024 Mar 19;4(4):1250-1262. doi: 10.1021/jacsau.3c00579. eCollection 2024 Apr 22. JACS Au. 2024. PMID: 38665673 Free PMC article. Review.
Cited by
-
Inhibition of Protein Aggregation and Endoplasmic Reticulum Stress as a Targeted Therapy for α-Synucleinopathy.Pharmaceutics. 2023 Jul 30;15(8):2051. doi: 10.3390/pharmaceutics15082051. Pharmaceutics. 2023. PMID: 37631265 Free PMC article. Review.
-
The Interplay between Alpha-Synuclein Clearance and Spreading.Biomolecules. 2015 Apr 14;5(2):435-71. doi: 10.3390/biom5020435. Biomolecules. 2015. PMID: 25874605 Free PMC article. Review.
-
Effects of Mutations and Post-Translational Modifications on α-Synuclein In Vitro Aggregation.J Mol Biol. 2022 Dec 15;434(23):167859. doi: 10.1016/j.jmb.2022.167859. Epub 2022 Oct 19. J Mol Biol. 2022. PMID: 36270580 Free PMC article. Review.
-
The small molecule ZPD-2 inhibits the aggregation and seeded polymerisation of C-terminally truncated α-Synuclein.FEBS J. 2024 Dec;291(23):5290-5304. doi: 10.1111/febs.17310. Epub 2024 Oct 27. FEBS J. 2024. PMID: 39462681 Free PMC article.
-
α-Synuclein pathology as a target in neurodegenerative diseases.Nat Rev Neurol. 2025 Jan;21(1):32-47. doi: 10.1038/s41582-024-01043-w. Epub 2024 Nov 28. Nat Rev Neurol. 2025. PMID: 39609631 Review.
References
-
- Bisaglia M, Mammi S, Bubacco L. Structural insights on physiological functions and pathological effects of alpha-synuclein. FASEB J. 2009;23:329–340. - PubMed
-
- Carrell RW, Lomas DA. Conformational disease. Lancet. 1997;350:134–138. - PubMed
-
- Conway KA, Harper JD, Lansbury PT., Jr Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid. Biochemistry. 2000;39:2552–2563. - PubMed
LinkOut - more resources
Full Text Sources